The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
Top Cited Papers
- 1 October 2015
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (10) , 1854-1860
Abstract
Objective To describe clinical outcomes of juvenile idiopathic arthritis (JIA) in a prospective inception cohort of children managed with contemporary treatments. Methods Children newly diagnosed with JIA at 16 Canadian paediatric rheumatology centres from 2005 to 2010 were included. Kaplan–Meier survival curves for each JIA category were used to estimate probability of ever attaining an active joint count of 0, inactive disease (no active joints, no extraarticular manifestations and a physician global assessment of disease activity 12 months after discontinuing treatment) and of receiving specific treatments. Results In a cohort of 1104 children, the probabilities of attaining an active joint count of 0 exceeded 78% within 2 years in all JIA categories. The probability of attaining inactive disease exceeded 70% within 2 years in all categories, except for RF-positive polyarthritis (48%). The probability of discontinuing treatment at least once was 67% within 5 years. The probability of attaining remission within 5 years was 46–57% across JIA categories except for polyarthritis (0% RF-positive, 14% RF-negative). Initial treatment included joint injections and non-steroidal anti-inflammatory drugs for oligoarthritis, disease-modifying antirheumatic drugs (DMARDs) for polyarthritis and systemic corticosteroids for systemic JIA. Conclusions Most children with JIA managed with contemporary treatments attain inactive disease within 2 years of diagnosis and many are able to discontinue treatment. The probability of attaining remission within 5 years of diagnosis is about 50%, except for children with polyarthritis.Keywords
This publication has 23 references indexed in Scilit:
- Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritisClinical Immunology, 2012
- Ongoing disease activity and changing categories in a long‐term nordic cohort study of juvenile idiopathic arthritisArthritis & Rheumatism, 2011
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic featuresArthritis Care & Research, 2011
- Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohortArthritis Care & Research, 2010
- Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective StudyRheumatology, 2009
- Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: Results of a Canadian multicenter, prospective inception cohort studyArthritis Care & Research, 2009
- Patterns of clinical remission in select categories of juvenile idiopathic arthritisArthritis & Rheumatism, 2005
- Outcome following onset of juvenile idiopathic inflammatory arthritis: I. Frequency of different outcomesRheumatology, 2005
- Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritisBest Practice & Research Clinical Rheumatology, 2002
- Preliminary definition of improvement in juvenile arthritisArthritis & Rheumatism, 1997